Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

But one of the rarest muscular disorders is also one of the most concerning. It's called myasthenia gravis and affects only about 37 out of every 100,000 people in the United States. Despite being ...

Today, I want to discuss myasthenia gravis. It's a rare autoimmune neuromuscular ... that's a general sense of fatigue. And there are multiple reasons for that kind of fatigue.

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.